Evidence map›Paper›PMID 41460255›Full record

ArticleCurrent microbiology2025

The Role of Talaromyces Marneffei Binding To CD86 in the CD86-CTLA4 Regulatory Pathway.

Shangrong Tang, Krishna Hamal, Yongjun Meng, Meilan Xu, Donghua Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shangrong TangDepartment of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, No.6 Shuang-yong Road, Nanning, 530021, People's Republic of China.
Krishna HamalDepartment of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, No.6 Shuang-yong Road, Nanning, 530021, People's Republic of China.
Yongjun MengDepartment of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, No.6 Shuang-yong Road, Nanning, 530021, People's Republic of China.
Meilan XuDepartment of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, No.6 Shuang-yong Road, Nanning, 530021, People's Republic of China.
Donghua LiuDepartment of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, No.6 Shuang-yong Road, Nanning, 530021, People's Republic of China. ldhgxmu@163.com.

Funding

National Natural Science Foundation of China 82260623Natural Science Foundation of Guangxi Zhuang Autonomous Region 2022GXNSFAA035457
6 · The paper itself

Abstract

Talaromyces marneffei (TM), an opportunistic pathogenic fungus, binds to CD86, which acts as a co-stimulatory molecule for CTLA4. CD86 activates CTLA4, which transmits inhibitory signals, yet its role in TM immune responses remains unclear. In this study, we investigated how the binding of TM to CD86 modulates the CD86-CTLA4 regulatory pathway. To establish the co-culture system of THP-1/THP-1-CD86-EGFP, TM, and Jurkat, Jurkat cells were first transfected with lentivirus to generate the target cell lines. The interactions among TM, CD86, and CTLA4 within this system were then investigated using confocal fluorescence microscopy. To evaluate changes in the expression levels of target factors, RT-qPCR and Western blotting were performed. Potential downregulated pathways were further identified through RNA sequencing (RNA-Seq) analysis. Additionally, the functional role of CTLA4 in the co-culture system was assessed by bactericidal assays. In the co-culture system, THP-1 macrophages engulfed TM, which bound to CD86 and formed immature phagosomes that subsequently escaped. Escaped TM interacted with Jurkat cells via CD86, activating CTLA4. Transcriptional levels of CD86 and CTLA4 initially increased and then decreased in the TM(+) vs. TM(-) comparison. After 24 h, OE showed significant differences in CD86 and CTLA4 (transcriptional and translational levels) vs. CON and NC, along with differences in IFN-γ, IL-5, and IL-13. At 48 h, CD86 and CTLA4 expression varied with THP-1/CD86-EGFP presence. RNA-seq showed TM proliferation and differentiation downregulated PI3K-Akt and T cell receptor pathways. The fungal killing assay indicated that CTLA4 may facilitate TM in evading immune-mediated damage. TM regulates the CD86-CTLA4 immune regulatory pathway by binding to the CD86 protein, thereby evading the immune killing of macrophages.

Indexed as

B7-2 AntigenCTLA-4 AntigenTalaromycesCoculture TechniquesHumansJurkat CellsMacrophagesProtein BindingSignal TransductionTHP-1 CellsB7-2 AntigenCD86 protein, humanCTLA-4 AntigenCTLA4 protein, human

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.